Caseware UK (AP4) 2023.0.135 2023.0.135 2023-10-312023-10-31false2022-11-01falseNo description of principal activity22falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13689543 2022-11-01 2023-10-31 13689543 2021-10-19 2022-10-31 13689543 2023-10-31 13689543 2022-10-31 13689543 c:Director1 2022-11-01 2023-10-31 13689543 d:MotorVehicles 2022-11-01 2023-10-31 13689543 d:MotorVehicles 2023-10-31 13689543 d:MotorVehicles 2022-10-31 13689543 d:MotorVehicles d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 13689543 d:OfficeEquipment 2022-11-01 2023-10-31 13689543 d:OfficeEquipment 2023-10-31 13689543 d:OfficeEquipment 2022-10-31 13689543 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 13689543 d:OtherPropertyPlantEquipment 2022-11-01 2023-10-31 13689543 d:OtherPropertyPlantEquipment 2023-10-31 13689543 d:OtherPropertyPlantEquipment 2022-10-31 13689543 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 13689543 d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 13689543 d:CurrentFinancialInstruments 2023-10-31 13689543 d:CurrentFinancialInstruments 2022-10-31 13689543 d:Non-currentFinancialInstruments 2023-10-31 13689543 d:Non-currentFinancialInstruments 2022-10-31 13689543 d:CurrentFinancialInstruments d:WithinOneYear 2023-10-31 13689543 d:CurrentFinancialInstruments d:WithinOneYear 2022-10-31 13689543 d:ShareCapital 2023-10-31 13689543 d:ShareCapital 2022-10-31 13689543 d:RetainedEarningsAccumulatedLosses 2023-10-31 13689543 d:RetainedEarningsAccumulatedLosses 2022-10-31 13689543 c:FRS102 2022-11-01 2023-10-31 13689543 c:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 13689543 c:FullAccounts 2022-11-01 2023-10-31 13689543 c:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 13689543 2 2022-11-01 2023-10-31 13689543 6 2022-11-01 2023-10-31 13689543 e:PoundSterling 2022-11-01 2023-10-31 iso4217:GBP xbrli:pure

Registered number: 13689543









ALCHEMY HEALTHCARE GROUP LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 OCTOBER 2023

 
ALCHEMY HEALTHCARE GROUP LIMITED
REGISTERED NUMBER: 13689543

BALANCE SHEET
AS AT 31 OCTOBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
45,548
-

Investments
 5 
100
100

  
45,648
100

Current assets
  

Debtors: amounts falling due within one year
 6 
15,723
1,256

Cash at bank and in hand
 7 
1,654
60,399

  
17,377
61,655

Debtors falling more than one year
 6 
25,000
-

  

Current Liabilities
  

Creditors: amounts falling due within one year
 8 
(11,514)
(13,232)

Net current assets
  
 
 
30,863
 
 
48,423

Total assets less current liabilities
  
76,511
48,523

  

Net assets
  
76,511
48,523


Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
76,509
48,521

  
76,511
48,523


Page 1

 
ALCHEMY HEALTHCARE GROUP LIMITED
REGISTERED NUMBER: 13689543
    
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 30 July 2024.




James Richard Cook
Director

The notes on pages 3 to 8 form part of these financial statements.
Page 2

 
ALCHEMY HEALTHCARE GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

1.


General information

Alchemy Healthcare Group Limited is a private company limited by shares and incorporated in England and Wales. The company registration number is 13689543. Its registered office is Calder & Co, 30 Orange Street, London, WC2H 7HF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are for Alchemy Healthcare Group Limited only as the company is a parent of a small group and not required to prepare consolidated financial statements.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 3

 
ALCHEMY HEALTHCARE GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

2.Accounting policies (continued)

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight line and reducing balance method..

Depreciation is provided on the following basis:

Motor vehicles
-
25%
Reducing balance
Office equipment
-
25%
Straight line
Other fixed assets
-
25%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Financial instruments

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment.
Page 4

 
ALCHEMY HEALTHCARE GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

2.Accounting policies (continued)


2.10
Financial instruments (continued)



Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversals. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.


Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from the suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest rate method. Discounting is omitted where the effect of discounting is immaterial.


Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 5

 
ALCHEMY HEALTHCARE GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

2.Accounting policies (continued)

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2022 - 2)


4.


Tangible fixed assets





Motor vehicles
Office equipment
Other fixed assets
Total

£
£
£
£



Cost or valuation


Additions
46,995
2,416
679
50,090



At 31 October 2023

46,995
2,416
679
50,090



Depreciation


Charge for the year on owned assets
4,314
142
85
4,541



At 31 October 2023

4,314
142
85
4,541



Net book value



At 31 October 2023
42,681
2,274
594
45,549



At 31 October 2022
-
-
-
-

Page 6

 
ALCHEMY HEALTHCARE GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

5.


Fixed asset investments





Investment in subsidiary company

£



Cost or valuation


At 1 November 2022
100



At 31 October 2023
100





6.


Debtors

2023
2022
£
£

Due after more than one year

Other debtors
25,000
-

25,000
-


2023
2022
£
£

Due within one year

Other debtors
207
66

Called up share capital not paid
2
2

Prepayments and accrued income
15,514
1,188

15,723
1,256



7.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
1,654
60,399

1,654
60,399


Page 7

 
ALCHEMY HEALTHCARE GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

8.


Creditors: Amounts falling due within one year

2023
2022
£
£

Amounts owed to group undertakings
100
100

Corporation tax
4,973
11,382

Other taxation and social security
3,824
-

Accruals and deferred income
2,617
1,750

11,514
13,232


Page 8